XconomyCRISPR Organs? eGenesis Raises $38M For Pig-To-Human TransplantsXconomySince then, eGenesis has also worked on a second goal with CRISPR-Cas9, which works like guided scissors to find a stretch of DNA and snip it out. Cofounder and chief scienti… Continue reading
XconomyCRISPR Organs? eGenesis Raises $38M For Pig-To-Human TransplantsXconomySince then, eGenesis has also worked on a second goal with CRISPR-Cas9, which works like guided scissors to find a stretch of DNA and snip it out. Cofounder and chief scienti… Continue reading
Armed with CRISPR and a $38M round, eGenesis tackles the Holy Grail of xenotransplantationEndpoints NewsBut Yang and her 10-member crew are using CRISPR gene editing technology to knock out problem antigens to address the rejection issue while proving … Continue reading
MIT Technology Review |
CRISPR May Speed Pig-to-Human Transplants
MIT Technology Review The plan, says the company, is to use the gene-editing method known as CRISPR to introduce extensive DNA modifications into pigs as a way of humanizing their organs so they won’t get rejected if transferred into a person. (The back of the T-shirt reads … |
Business Insider |
A startup cofounded by a 30-year-old just got $38 million to revolutionize the way we transplant organs
Business Insider Egenesis, a startup that’s using the gene-editing tool CRISPR to make pig organs viable for transplants into people, just raised $38 million. The company, which launched back in 2015 and is co-founded by Harvard geneticist George Church and 30-year old … |
MedCity News |
Allergan (AGN) and Editas Tie Up to Treat Eye Diseases
Nasdaq The agreement includes early stage, first-in-class ocular programs targeting serious diseases based on Editas Medicine’s CRISPR genome editing platform, including CRISPR/Cas9 and CRISPR/Cpf1. CRISPR (Clustered Regularly Interspaced Short … Allergan and Editas Medicine Enter into Strategic R&D Alliance to Discover and Develop CRISPR Genome Editing …GlobeNewswire (press release) Editas, Allergan Ink $90M CRISPR-Based Eye Drug DealGenomeWeb Allergan and Editas announce $90M CRISPR dealMedCity News Labiotech.eu (blog) –Pharmaceutical Executive (press release) (registration) (blog) all 109 news articles » |